Abstract
MicroRNAs (miRNAs) are single-stranded noncoding RNAs of 21–23 nucleotides, which regulate the expression of genes by binding to the 3′ untranslated regions of target messenger RNAs (mRNAs). MicroRNAs down-regulate gene expression by either inhibiting translation or accelerating the degradation of the mRNA. It is estimated that miRNAs are involved in the regulation of about 30 % of all genes and almost every genetic pathway, making miRNAs an important class of gene regulators. Variations in miRNA expression are involved in many human diseases including cancer, immune disorders, diabetes, and cardiovascular diseases. Thus, small molecule modifiers of miRNA function have potential as new therapeutic agents, as probes for the elucidation of detailed mechanisms of miRNA function and regulation, and as tools for the discovery of new targets for the treatment of human diseases. A variety of different assay systems have been developed and used in the discovery of small molecule modifiers of miRNA function. Identified small molecules regulate the miRNA pathway in either a general or a miRNA-specific fashion. The discovery and development of these molecules demonstrates that the miRNA pathway represents a feasible small molecule target. Several of these small molecules have also shown therapeutic potential in cell based experiments, supporting the idea that modifiers of miRNA function could lead to the identification of new drugs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lee R, Feinbaum R, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843–854
Reinhart B, Slack F, Basson M, Pasquinelli A, Bettinger J et al (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403:901–906
Pasquinelli A, Reinhart B, Slack F, Martindale M, Kuroda M et al (2000) Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408:86–89
Winter J, Jung S, Keller S, Gregory R, Diederichs S (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11:228–234
Ghildiyal M, Zamore P (2009) Small silencing RNAs: an expanding universe. Nat Rev Genet 10:94–108
Carthew R, Sontheimer E (2009) Origins and Mechanisms of miRNAs and siRNAs. Cell 136:642–655
Garzon R, Marcucci G, Croce C (2010) Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 9:775–789
Shenouda S, Alahari S (2009) MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev 28:369–378
Esquela-Kerscher A, Slack F (2006) Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6:259–269
Carthew R (2006) Gene regulation by microRNAs. Curr Opin Genet Dev 16:203–208
Vasudevan S, Tong Y, Steitz J (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318:1931–1934
Vasudevan S, Tong Y, Steitz JA (2008) Cell-cycle control of microRNA-mediated translation regulation. Cell Cycle 7:1545–1549
Appasani K (2008) MicroRNAs: from basic science to disease biology. Cambridge University Press, Cambridge
Sevignani C, Calin G, Siracusa L, Croce C (2006) Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome 17:189–202
Zhang S, Chen L, Jung E, Calin G (2010) Targeting MicroRNAs With Small Molecules: From Dream to Reality. Clin Pharmacol Ther 87:754–758
Medina PP, Nolde M, Slack FJ (2010) OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467:86–90
Du T, Zamore P (2005) microPrimer: the biogenesis and function of microRNA. Development 132:4645–4652
Lee Y, Ahn C, Han J, Choi H, Kim J et al (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425:415–419
Bernstein E, Caudy A, Hammond S, Hannon G (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409:363–366
Grishok A, Pasquinelli A, Conte D, Li N, Parrish S et al (2001) Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106:23–34
Hutvágner G, McLachlan J, Pasquinelli A, Bálint E, Tuschl T et al (2001) A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293:834–838
Ketting R, Fischer S, Bernstein E, Sijen T, Hannon G et al (2001) Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev 15:2654–2659
Yi R, Qin Y, Macara I, Cullen B (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17:3011–3016
Pillai RS (2005) MicroRNA function: multiple mechanisms for a tiny RNA? RNA 11:1753–1761
He L, Hannon G (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5:522–531
Bartel D (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
Chan S, Slack F (2006) microRNA-mediated silencing inside P-bodies. RNA Biol 3:97–100
Lelandais-Brière C, Sorin C, Declerck M, Benslimane A, Crespi M et al (2010) Small RNA diversity in plants and its impact in development. Curr Genomics 11:14–23
Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11:597–610
Zhang X, Zeng Y (2010) Regulation of mammalian microRNA expression. J Cardiovasc Transl Res 3:197–203
He L, Thomson J, Hemann M, Hernando-Monge E, Mu D et al (2005) A microRNA polycistron as a potential human oncogene. Nature 435:828–833
Calin G, Sevignani C, Dumitru C, Hyslop T, Noch E et al (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101:2999–3004
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S et al (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99:15524–15529
Saito Y, Liang G, Egger G, Friedman J, Chuang J et al (2006) Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9:435–443
Zhang L, Huang J, Yang N, Greshock J, Megraw M et al (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A 103:9136–9141
Shi X, Tepper C, deVere White R (2008) Cancerous miRNAs and their regulation. Cell Cycle 7:1529–1538
O’Donnell K, Wentzel E, Zeller K, Dang C, Mendell J (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435:839–843
Kim J, Inoue K, Ishii J, Vanti W, Voronov S et al (2007) A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317:1220–1224
Thomson J, Newman M, Parker J, Morin-Kensicki E, Wright T et al (2006) Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 20:2202–2207
Davis B, Hilyard A, Lagna G, Hata A (2008) SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454:56–61
Trabucchi M, Briata P, Garcia-Mayoral M, Haase A, Filipowicz W et al (2009) The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 459:1010–1014
Viswanathan S, Daley G (2010) Lin28: A microRNA regulator with a macro role. Cell 140:445–449
Hagan J, Piskounova E, Gregory R (2009) Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells. Nat Struct Mol Biol 16:1021–1025
Heo I, Joo C, Cho J, Ha M, Han J et al (2008) Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell 32:276–284
Esau C (2008) Inhibition of microRNA with antisense oligonucleotides. Methods 44:55–60
Veedu R, Wengel J (2010) Locked nucleic acids: promising nucleic acid analogs for therapeutic applications. Chem Biodivers 7:536–542
Brown B, Naldini L (2009) Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat Rev Genet 10:578–585
Liu Z, Sall A, Yang D (2008) MicroRNA: An emerging therapeutic target and intervention tool. Int J Mol Sci 9:978–999
Grünweller A, Hartmann R (2007) Locked nucleic acid oligonucleotides: the next generation of antisense agents? BioDrugs 21:235–243
Ebert M, Neilson J, Sharp P (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4:721–726
Carè A, Catalucci D, Felicetti F, Bonci D, Addario A et al (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13:613–618
Zhang S, Chen L, Jung E, Calin G (2010) Targeting microRNAs with small molecules: from dream to reality. Clin Pharmacol Ther 87:754–758
Davies B, Arenz C (2006) A homogenous assay for micro RNA maturation. Angew Chem Int Ed Engl 45:5550–5552
Shan G, Li Y, Zhang J, Li W, Szulwach K et al (2008) A small molecule enhances RNA interference and promotes microRNA processing. Nat Biotechnol 26:933–940
Bhanot SK, Singh M, Chatterjee NR (2001) The chemical and biological aspects of fluoroquinolones: reality and dreams. Curr Pharm Des 7:311–335
Watashi K, Yeung M, Starost M, Hosmane R, Jeang K (2010) Identification of small molecules that suppress microRNA function and reverse tumorigenesis. J Biol Chem 285:24707–24716
Chiu Y, Dinesh C, Chu C, Ali A, Brown K et al (2005) Dissecting RNA-interference pathway with small molecules. Chem Biol 12:643–648
Calin G, Dumitru C, Shimizu M, Bichi R, Zupo S et al (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99:15524–15529
Dong JT, Boyd JC, Frierson HF (2001) Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer. Prostate 49:166–171
Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M et al (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 102:13944–13949
Baudry A, Mouillet-Richard S, Schneider B, Launay J, Kellermann O (2010) miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science 329:1537–1541
Tong A, Nemunaitis J (2008) Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther 15:341–355
Ciafrè S, Galardi S, Mangiola A, Ferracin M, Liu C et al (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334:1351–1358
Iorio M, Ferracin M, Liu C, Veronese A, Spizzo R et al (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065–7070
Si M, Zhu S, Wu H, Lu Z, Wu F et al (2007) miR-21-mediated tumor growth. Oncogene 26:2799–2803
Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob S et al (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133:647–658
Corsten M, Miranda R, Kasmieh R, Krichevsky A, Weissleder R et al (2007) MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 67:8994–9000
Mattie M, Benz C, Bowers J, Sensinger K, Wong L et al (2006) Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5:24
Wickramasinghe N, Manavalan T, Dougherty S, Riggs K, Li Y et al (2009) Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res 37:2584–2595
Bhat-Nakshatri P, Wang G, Collins N, Thomson M, Geistlinger T et al (2009) Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res 37:4850–4861
Shin VY, Jin H, Ng EK, Cheng AS, Chong WW et al (2010) NF-kappaB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors. Carcinogenesis
Longley DB, Harkin DP, Johnston PG (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3:330–338
Rossi L, Bonmassar E, Faraoni I (2007) Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro. Pharmacol Res 56:248–253
Valeri N, Gasparini P, Braconi C, Paone A, Lovat F et al (2010) MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc Natl Acad Sci U S A 107:21098–21103
Tomimaru Y, Eguchi H, Nagano H, Wada H, Tomokuni A et al (2010) MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells. Br J Cancer 103:1617–1626
Zhou J, Zhou Y, Yin B, Hao W, Zhao L et al (2010) 5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro. Oncol Rep 23:121–128
Shah MY, Pan X, Fix LN, Farwell MA, Zhang B (2011) 5-Fluorouracil drug alters the microRNA expression profiles in MCF-7 breast cancer cells. J Cell Physiol 226:1868–1878
Gumireddy K, Young D, Xiong X, Hogenesch J, Huang Q et al (2008) Small-molecule inhibitors of microrna miR-21 function. Angew Chem Int Ed Engl 47:7482–7484
Schmittgen TD, Jiang J, Liu Q, Yang L (2004) A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Res 32:e43
Chang J, Nicolas E, Marks D, Sander C, Lerro A et al (2004) miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 1:106–113
Esau C, Davis S, Murray S, Yu X, Pandey S et al (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3:87–98
Parkin D, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
Lin C, Gong H, Tseng H, Wang W, Wu J (2008) miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 375:315–320
Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S et al (2007) Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67:6092–6099
Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S et al (2008) MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 27:5651–5661
Yang JD, Roberts LR (2010) Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 7:448–458
Jopling C, Yi M, Lancaster A, Lemon S, Sarnow P (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309:1577–1581
Jopling C, Norman K, Sarnow P (2006) Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122. Cold Spring Harb Symp Quant Biol 71:369–376
Lanford R, Hildebrandt-Eriksen E, Petri A, Persson R, Lindow M et al (2010) Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327:198–201
Young D, Connelly C, Grohmann C, Deiters A (2010) Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. J Am Chem Soc 132:7976–7981
Yi M, Lemon S (2004) Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells. J Virol 78:7904–7915
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Connelly, C., Deiters, A. (2013). Small-Molecule Regulation of MicroRNA Function. In: Alahari, S. (eds) MicroRNA in Cancer. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4655-8_8
Download citation
DOI: https://doi.org/10.1007/978-94-007-4655-8_8
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4654-1
Online ISBN: 978-94-007-4655-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)